Feasibility of Wearable-Based Continuous Temperature Monitoring (NCT07397988) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Feasibility of Wearable-Based Continuous Temperature Monitoring
Switzerland12 participantsStarted 2026-03
Plain-language summary
The aim of this study is to evaluate the feasibility of collecting synchronised continuous temperature data using wearable devices and a continuous core temperature reference under real-world conditions. The study focuses on workflow execution, data continuity, secure retrieval, and time-alignment without diagnostic or therapeutic intent.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Written informed consent obtained prior to any project-specific procedures.
* Age 18 years or older at enrolment.
* Able and willing to comply with project procedures, including capsule ingestion, continuous wearable use for around 48 hours, and adherence to study instructions.
* Able to swallow the ingestible temperature capsule without difficulty.
* No contraindication to ingestible thermometry as assessed by the investigator.
Exclusion Criteria:
General:
* Body weight \< 36 kg.
* Women who are pregnant.
* Participation in another clinical investigation involving an investigational medicinal product or medical device within the 30 days preceding enrolment or previous enrolment in the current project.
* Enrolment of the Principal Investigator, project staff, their family members, employees, or other dependent persons.
* Inability to provide valid informed consent or significant language barrier preventing adequate understanding of procedures.
Implants \& MRI:
* Presence of any active Implantable Medical Device (AIMD), including Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Deep Brain Stimulation (DBS) devices, or Left Ventricular Assist Devices (LVADs).
* Requirement for MRI scanning during the seven days following the capsule intake.
Cognitive/Physical Status:
* Unconscious patients (prior to ingestion).
* Patients with special needs or disabilities preventing safe autonomous swallowing.
Gastrointestinal:
* Known history of dysp…